Monthly Archives: November 2021

//November

CPCS IT: Have you selected your system ahead of the upcoming deadline?

As previously reported, the national procurement model which is currently supporting contractors’ delivery of the Community Pharmacist Consultation Service (CPCS), will come to an end at the end of March 2022. Time is running out for contractors to complete their transition to their own CPCS IT systems. It is imperative that contractors planning to continue...

By |November 29th, 2021|Lexpos News|Comments Off on CPCS IT: Have you selected your system ahead of the upcoming deadline?

Medicine Supply Notification: Diamorphine 5mg and 10mg powder for solution for injection ampoules – Updated

Update: (10/01/2022) Addition of 10mg diamorphine ampoules to the notification, both strengths will be unavailable until February 2022. MSN/2021/062 Tier 2 – medium impact Date of issue: 29/11/2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Diamorphine 5mg powder for solution for injection ampoules. Diamorphine 5mg ampoules are out...

By |November 29th, 2021|Lexpos News|Comments Off on Medicine Supply Notification: Diamorphine 5mg and 10mg powder for solution for injection ampoules – Updated

Medicine Supply Notification: Sulfasalazine (Salazopyrin En-Tabs® ) 500mg tablets

MSN/2021/061 Tier 1 – low impact Date of issue: 29/11/2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfasalazine (Salazopyrin En-Tabs®) 500mg tablets Pfizer are out of stock of Salazopyrin En-Tabs® until w/c 20 December 2021. Generic versions of sulfasalazine 500mg gastro-resistant tablets remain available.  SPS MI have advised...

By |November 29th, 2021|Lexpos News|Comments Off on Medicine Supply Notification: Sulfasalazine (Salazopyrin En-Tabs® ) 500mg tablets

MHRA Class 4 Medicines Defect Information: Mometasone Furoate 50 microgram/Dose Nasal Spray

Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd Drug alert number: EL (22)A/33 Date issued: 29 November 2021 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd...

By |November 29th, 2021|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Mometasone Furoate 50 microgram/Dose Nasal Spray

Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine) Mawdsley-Brooks & Company Limited

Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited Drug alert number: EL (22)A/32 Date issued: 29 November 2021 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited Mawdsley-Brooks & Company Limited...

By |November 29th, 2021|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine) Mawdsley-Brooks & Company Limited